TOPK activation-mediated anti-inflammation is also suggested to be involved in remote limb ischemic postconditioning invoked protection against renal ischemia/reperfusion injury; thus, TOPK is a promising target for new drug development in the treatment of ischemic stroke. This evidence concerns the gene PBK and ischemic stroke.